Case report reveals a rare acute hemolytic transfusion reaction linked to cold reactive anti-P1 antibodies, indicating improved testing methods may be necessary.
Anti‐P1 alloantibody is predominantly an immunoglobulin M class, cold reactive antibody that is non‐reactive at 37°C in routine pre‐transfusion serology and thus generally regarded as clinically insignificant. However, rare clinically significant anti‐P1 antibodies can cause an acute hemolytic transfusion reaction (AHTR), and routine pre‐transfusion testing at 37°C may miss such antibodies. We report a case of AHTR caused by an anti‐P1 antibody detectable only at 4°C, which evaded detection by unexpected antibody screening performed at 37°C. A 65‐year‐old woman with blood group B, RhD positive developed AHTR within 24 h following red blood cell transfusion. She presented with coffee‐colored urine, markedly elevated bilirubin and lactate dehydrogenase concentrations, and a progressive decline in hemoglobin concentrations. Pre‐transfusion antibody screening at 37°C was negative. A retrospective serological analysis identified anti‐P1 exclusively at 4°C, which was confirmed by pigeon egg white inhibition. The patient was P1 negative; incompatibility occurred only with the P1‐positive donor unit. After transfusion of P1 antigen‐negative red blood cells, the hemolysis resolved and hemoglobin concentrations recovered. In patients with a repeated transfusion history, serological testing at 37°C and 4°C, in conjunction with antigen‐matched selection, is essential to prevent AHTR caused by clinically significant cold reactive antibodies.
No takes yet. Share an insight, caveat, or question.
Ke et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: